Skin diseases in consequence of endocrine alterations

References

• Grandhe N P, Bhansali A, Dogra S, Kumar B. Acanthosis nigricans: Relation with type 2 diabetes mellitus, anthropometric variables, and body mass in Indians. Postgrad Med J 2005; 81(958)541–544
   PubMed Web of Science ®Google Scholar
• Selkin B A, Reynolds R V, Selkin G. Cutaneous manifestations of internal malignancy, UptoDate® 2005. Available at: http://www.utdol.com
   Google Scholar
• Mekhail T M, Markman M. Acanthosis nigricans with endometrial carcinoma: Case report and review of the literature. Gynecol Oncol 2002; 84(2)332–334
   PubMed Web of Science ®Google Scholar
• Torley D, Bellus G A, Munro C S. Genes, growth factors and acanthosis nigricans. Br J Dermatol 2002; 147(6)1096–1101
   PubMed Web of Science ®Google Scholar
• Garcia Hidalgo L. Dermatological complications of obesity. Am J Clin Dermatol 2002; 3(7)497–506
   PubMedGoogle Scholar
• McPhaul M J, Young M. Complexities of androgen action. J Am Acad Dermatol 2001; 45(Suppl)S87–S94
   Google Scholar
• Oh B R, Kim S J, Moon J D, Kim H N, Kwon D D, Won Y H, Ryu S B, Park Y I. Association of benign prostatic hyperplasia with male pattern baldness. Urology 1998; 51(5)744–748
   PubMed Web of Science ®Google Scholar
• Gruber D, Sator M, Frigo P, Knogler W, Huber J C. Korrelation der Hautfaltendicke mit der Knochendichte, Östradiol, FSH und Prolactinspiegel bci 231 Frauen. Wien Klin Wochenschr 1995; 107(20)622–625
   PubMed Web of Science ®Google Scholar
• Denti L, Pasolini G, Sanfelici L, Benedetti R, Cecchetti A, Ceda G P, Ablondi F, Valenti G. Aging-related decline of gonadal function in healthy men: Correlation with body composition and lipoproteins. J Am Geriatr Soc 2000; 48(1)51–58
   PubMed Web of Science ®Google Scholar
• Hoffmann R. Male androgenetic alopecia. Clin Exp Derm 2002; 27: 373–382
   PubMed Web of Science ®Google Scholar
• Kasten R, Pfirrmann G, Voigtlander V. Klinefelter's syndrome associated with mixed connective tissue disease (Sharp's syndrome) and thrombophilia with postthrombotic syndrome. J Dtsch Dermatol Ges 2005; 3(8)623–626
   PubMedGoogle Scholar
• Swerdlow A J, Schoemaker M J, Higgins C D, Wright A F, Jacobs P A. UK Clinical Cytogenetics Group. Cancer incidence and mortality in men with Klinefelter syndrome: A cohort study. J Natl Cancer Inst 2005; 97(16)1204–1210
   PubMedGoogle Scholar
• Hoffmann R. TrichoScan: A novel tool for the analysis of hair growth in vivo. J Investig Dermatol Symp Proc 2003; 8(1)109–115
   PubMedGoogle Scholar
• Öberg K. Carcinoid tumors, carcinoid syndrome, and related disorders. Williams Textbook of Endocrinology. 10th ed, P R Larsen, H M Kronenberg, S Melmed, K S Polonsky. Saunders, Philadelphia 2003; 1857–1870
   Google Scholar
• Rapaport M J. Follow-up of 1 mg finasteride treatment of male pattern baldness – difference between clinical trials and private office follow-up: Influences on prescribing habits evaluated. Dermatol Surg 2004; 30(5)761–763
   PubMed Web of Science ®Google Scholar
• Modlin I M, Shapiro M D, Kidd M. An analysis of rare carcinoid tumors: Clarifying these clinical conundrums. World J Surg 2005; 29(1)92–101
   PubMed Web of Science ®Google Scholar
• Bell H K, Poston G J, Vora J, Wilson N JE. Cutaneous manifestations of the malignant carcinoid syndrome. Br J Dermatol, 152: 71–75
   PubMed Web of Science ®Google Scholar
• Sitaraman S V, Goldfinger S T. The carcinoid syndrome, UpToDate (13.2) June 2005. Available at: http://www.utdol. com
   Google Scholar
• Freinkel R K, Freinkel N. Cutaneous manifestations of endocrine disorders. Dermatology in general medicine, T B Fitzpatrick, A Z Eisen, K Wolff, J M Freedberg, K F Austen. McGraw Hill, New York 1987, Chapter 174
   Google Scholar
• Stewart P M. The adrenal cortex. Williams textbook of endocrinology, 10th ed, P R Larsen, H M Kronenberg, S Melmed, K S Polonsky. Saunders, Philadelphia 2003; 491–551
   Google Scholar
• Ponec M. Hormone receptors in the skin. Dermatology in general medicine, T B Fitzpatrick, A Z Eisen, K Wolff, J M Freedberg, K F Austen. McGraw Hill, New York 1987, Chapter 31
   Google Scholar
• Payne D N, Adcock I M. Molecular mechanisms of corticosteroid actions. Paediatr Respir Rev 2001; 2(2)145–150
   PubMedGoogle Scholar
• Rosmond R. The glucocorticoid receptor gene and its association to metabolic syndrome. Obes Res 2002; 10(10)1078–1086
   PubMedGoogle Scholar
• Brazzini B, Pimpinelli N. New and established topical corticosteroids in dermatology: Clinical pharmacology and therapeutic use. Am J Clin Dermatol 2002; 3(1)47–58
   PubMedGoogle Scholar
• Wozniak K D, Bar M. Zur bedeutung von hautveränderungen beim diabetes mellitus. Z Gesamte Inn Med 1990; 45(22)669–673
   PubMedGoogle Scholar
• Richardson T, Kerr D. Skin-related complications of insulin therapy: Epidemiology and emerging management strategies. Am J Clin Dermatol 2003; 4(10)661–667
   PubMed Web of Science ®Google Scholar
• Greenman R L, Panasyuk S, Wang X, Lyons T E, Dinh T, Longoria L, Giurini J M, Freeman J, Khaodhiar L, Veves A. Early changes in the skin microcirculation and muscle metabolism of the diabetic foot. Lancet 2005; 366(9498)1711–1717
   PubMed Web of Science ®Google Scholar
• Freinkel R K, Freinkel N. Cutaneous manifestations of endocrine disorders. Dermatology in general medicine, T B Fitzpatrick, A Z Eisen, K Wolff, J M Freedberg, K F Austen. McGraw Hill, New York 1987, Chapter 174
   Google Scholar
• Pinzur M, Freeland R, Juknelis D. The association between body mass index and foot disorders in diabetic patients. Foot Ankle Int 2005; 26(5)375–377
   PubMed Web of Science ®Google Scholar
• Mendonca D A, Cosker T, Makwana N K. Vacuum-assisted closure to aid wound healing in foot and ankle surgery. Foot Ankle Int 2005; 26(9)761–766
   PubMed Web of Science ®Google Scholar
• Tom W L, Peng D H, Allaei A, Hsu D, Hata T R. The effect of short-contact topical tretinoin therapy for foot ulcers in patients with diabetes. Arch Dermatol 2005; 141(11)1373–1377
   PubMedGoogle Scholar
• Brownlee M, Aiello L P, Friedman E, Vinik A I, Nesto R W, Boulton J M. Complications of diabetes mellitus. Williams textbook of endocrinology, 10th ed, P R Larsen, H M Kronenberg, S Melmed, K S Polonsky. Saunders, Philadelphia 2003; 1509–1584
   Google Scholar
• Frykberg R G. An evidence-based approach to diabetic foot infections. Am J Surg 2003; 186(5A)S44–S54
   Google Scholar
• Robbins J M. Treatment of onychomycosis in the diabetic patient population. J Diabetes Complications 2003; 17(2)98–104
   PubMed Web of Science ®Google Scholar
• McCulloch D K. Evaluation of the diabetic foot, UptoDate® 2005. Available at: http://www.utdol.com
   Google Scholar
• Chuang T Y, Lewis D A, Spandau D F. Decreased incidence of nonmelanoma skin cancer in patients with type 2 diabetes mellitus using insulin: A pilot study. Br J Dermatol 2005; 153(3)552–557
   PubMed Web of Science ®Google Scholar
• Raine-Fenning N J, Brincat M P, Muscat-Baron Y. Skin aging and menopause: Implications for treatment. Am J Clin Dermatol 2003; 4(6)371–378
   PubMed Web of Science ®Google Scholar
• Wildt L, Sir-Peterman T. Oestrogen and age estimations of perimenopausal women. Lancet 1999; 354: 224
   PubMed Web of Science ®Google Scholar
• Niewöhner C B, Nuttall R Q. Gynecomastia in a hospitalized male population. Amer J Med 1984; 77: 633–638
   PubMed Web of Science ®Google Scholar
• Carney J A, Hruska L S, Beauchamp G D, Gordon H. Dominant inheritance of the complex of myxomas, spotty pigmentation, and endocrine overactivity. Mayo Clin Proc 1986; 61(3)165–172
   PubMed Web of Science ®Google Scholar
• Carney J A. Carney complex: The complex of myxomas, spotty pigmentation, endocrine overactivity and schwannomas. Semin Dermatol 1995; 14: 90
   PubMedGoogle Scholar
• Nieman L K. Cushing's syndrome due to ACTH-independent micronodular and macronodular adrenal hyperplasia, Available at: UpToDate Version 13.3, September 8, 2004
   Google Scholar
• Kyle R A. POEMS syndrome (osteosclerotic myeloma), Available at: UpToDate September 12, 2005
   Google Scholar
• Dispenzieri A, Kyle R A, Lacy M Q, et al. POEMS syndrome. Definitions and long-term outcome. Blood 2003; 101: 2496
   PubMed Web of Science ®Google Scholar
• Perniciaro C. POEMS syndrome. Semin Dermatol 1995; 14: 162
   PubMedGoogle Scholar
• Rosenberg P M, Goldfinger S T. Glucagonoma and the glucagonoma syndrome, UptoDate® 2005. Available at: http://www.utdol.com
   Google Scholar
• van Beek A P, de Haas E R, van Vloten W A, Lips C J, Roijers J F, Canninga-van Dijk M R. The glucagonoma syndrome and necrolytic migratory erythema: A clinical review. Eur J Endocrinol 2004; 151(5)531–537
   PubMed Web of Science ®Google Scholar
• Chastain M A. The glucagonoma syndrome: A review of its features and discussion of new perspectives. Am J Med Sci 2001; 321(5)306–320
   PubMed Web of Science ®Google Scholar
• Zhang M, Xu X, Shen Y, Hu Z H, Wu L M, Zheng S S. Clinical experience in diagnosis and treatment of glucagonoma syndrome. Hepatobiliary Pancreat Dis Int 2004; 3(3)473–475
   PubMedGoogle Scholar
• Quatresooz P, Hermanns-Le T, Ciccarelli A, Beckers A, Pierard G E. Tensegrity and type 1 dermal dendrocytes in acromegaly. Eur J Clin Invest 2005; 35(2)133–139
   PubMed Web of Science ®Google Scholar
• LeRoith D, Roberts C T, Jr. The insulin-like growth factor system and cancer. Cancer Lett 2003; 195(2)127–137
   PubMed Web of Science ®Google Scholar
• Renehan A G, Zwahlen M, Minder C, O'Dwyer S T, Shalet S M, Egger M. Insulin-like growth factor (IGF)-I, IGF binding protein-3, and cancer risk: Systematic review and meta-regression analysis. Lancet 2004; 363(9418)1346–1353
   PubMed Web of Science ®Google Scholar
• Carroll P V, Christ E R, Bengtsson B A, Carlsson L, Christiansen J S, Clemmons D, Hintz R, Ho K, Laron Z, Sizonenko P, et al. Growth hormone deficiency in adulthood and the effects of growth hormone replacement: A review. Growth Hormone Research Society Scientific Committee. J Clin Endocrinol Metab 1998; 83(2)382–395
   PubMed Web of Science ®Google Scholar
• Pinkus. 1902, (cited in Moll et al., 2005)
   Google Scholar
• Moll I, Roessler M, Brandner J M, Eispert A C, Houdek P, Moll R. Human Merkel cells – aspects of cell biology, distribution and functions. Eur J Cell Biol 2005; 84(2–3)259–271
   PubMed Web of Science ®Google Scholar
• Koljonen V, Haglund C, Tukiainen E, Bohling T. Neuroendocrine differentiation in primary Merkel cell carcinoma – possible prognostic significance. Anticancer Res 2005; 25(2A)853–858
   PubMed Web of Science ®Google Scholar
• Larsen P R, Davies T F, Schlumberger M J, Hay I D. Thyroid physiology and diagnostic evalulation of patients with thyroid disorders. Williams textbook of endocrinology. 10th ed, P R Larsen, H M Kronenberg, S Melmed, K S Polonsky. Saunders, Philadelphia 2003; 33–37
   Google Scholar
• O'Donnell B F, Francis D M, Swana G T, Seed P T, Kobza Black A, Greaves M W. Thyroid autoimmunity in chronic urticaria. Br J Dermatol 2005; 153(2)331–335
   PubMed Web of Science ®Google Scholar
• Fatourechi V. Pretibial myxedema: Pathophysiology and treatment options. Am J Clin Dermatol 2005; 6(5)295–309
   PubMed Web of Science ®Google Scholar
• Davies T F, Larsen R P. Thyrotoxicos. Williams textbook of endocrinology. 10th ed, P R Larsen, H M Kronenberg, S Melmed, K S Polonsky. Saunders, Philadelphia 2003; 374–422
   Google Scholar
• Stumpf W E. The endocrinology of sunlight and darkness. Complementary roles of vitamin D and pineal hormones. Naturwissenschaften 1988; 75(5)247–251
   PubMed Web of Science ®Google Scholar
• Scarlett W L. Ultraviolet radiation: Sun exposure, tanning beds, and vitamin D levels. What you need to know and how to decrease the risk of skin cancer. J Am Osteopath Assoc 2003; 103(8)371–375
   PubMedGoogle Scholar
• Bollinger Bollag W, Bollag R J. 1,25-Dihydroxyvitamin D(3), phospholipase D and protein kinase C in keratinocyte differentiation. Mol Cell Endocrinol 2001; 177(1–2)173–182
   PubMed Web of Science ®Google Scholar
• Kira M, Kobayashi T, Yoshikawa K. Vitamin D and the skin. J Dermatol 2003; 30(6)429–437
   PubMed Web of Science ®Google Scholar
• Holick M F. Sunlight and vitamin D for bone health and prevention of autoimmune diseases, cancers, and cardiovascular disease. Am J Clin Nutr 2004; 80(6 Suppl)S1678–S88
   PubMed Web of Science ®Google Scholar
• Njoo M D, Westerhof W. Vitiligo. Pathogenesis and treatment. Am J Clin Dermatol 2001; 2(3)167–181
   PubMedGoogle Scholar
• Huang C L, Nordlund J J, Boissy R. Vitiligo: A manifestation of apoptosis?. Am J Clin Dermatol 2002; 3(5)301–308
   PubMedGoogle Scholar
• Kadekaro A L, Kanto H, Kavanagh R, Abdel-Malek Z A. Significance of the melanocortin 1 receptor in regulating human melanocyte pigmentation, proliferation, and survival. Ann NY Acad Sci 2003; 994: 359–365
   PubMed Web of Science ®Google Scholar
• Wankowicz-Kalinska A, Le Poole C, van den Wijngaard R, Storkus W J, Das P K. Melanocyte-specific immune response in melanoma and vitiligo: Two faces of the same coin?. Pigment Cell Res 2003; 16(3)254–260
   PubMedGoogle Scholar
• Luger T A, Schwarz T, Kalden H, Scholzen T, Schwarz A, Brzoska T. Role of epidermal cell-derived α-melanocyte stimulating hormone in ultraviolet light mediated local immunosuppression. Ann NY Acad Sci 1999; 20(885)209–216
   Google Scholar
• Luger T A, Scholzen T E, Brzoska T, Bohm M. New insights into the functions of α-MSH and related peptides in the immune system. Ann NY Acad Sci 2003; 994: 133–140
   PubMed Web of Science ®Google Scholar